Relative binding activity of new antigestagens with progesterone receptors in human hyperplastic endometrium

Other OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-13 ⓘ

Researchers analyzed progesterone receptor binding in hyperplastic endometrium associated with adenomyosis, finding that antigestagen affinity changes allow for individualized hormone therapy correction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We determined the content and binding capacity of progesterone receptors in the endometrium of patients with adenomatous and fibroid polyps, adenocystic hyperplasia, and atypical hyperplasia before and after gestagen therapy. Hyperplasia of the endometrium was accompanied by changes in affinity of cytosolic progesterone receptors for antigestagens, which provides the possibility of individual correction of hormone therapy.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Hyperplasia Estrogen Receptor Modulators Receptors, Progesterone 17 alpha-Hydroxyprogesterone Caproate Adult Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Estrogen Receptor Modulators Estrogen Receptor Modulators Female Humans Hydroxyprogesterones Hydroxyprogesterones In Vitro Techniques Kinetics Middle Aged Receptors, Progesterone Receptors, Progesterone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:01:06.509505+00:00
unpaywall
last seen: 2026-10-22T06:24:31.118836+00:00
License: CC0 · commercial use OK